Delineation of immunoreactive, conserved regions in the external glycoprotein of the human immunodeficiency virus type 1
- PMID: 1380259
- DOI: 10.1089/aid.1992.8.1125
Delineation of immunoreactive, conserved regions in the external glycoprotein of the human immunodeficiency virus type 1
Abstract
Immunization of mice and rats with purified external glycoprotein gp120 from two divergent human immunodeficiency virus type 1 (HIV-1) isolates resulted in the development of seven hybridomas secreting monoclonal antibodies able to recognize regions of gp120 which are common among divergent strains of HIV-1. These monoclonal antibodies cross-reacted with env glycoproteins from one African (Rutz), one Haitian (RF), and three North American viral isolates, namely IIIB, MN, and 451 by either immunoblot or radioimmunoprecipitation assays. All recognized denatured gp120 in immunoblots with the exception of one which required a conformationally intact glycoprotein for reactivity. The gp120 epitopes identified by these antibodies were mapped by screening of an env gene library in the lambda gt11 expression system. Three out of four epitopes were found to reside in the amino-terminal half of gp120 (Cys9 to Cys35, Thr44 to Glu72 and Val108 to Met130), the other was located in the middle region (Thr221 to Ser255). By virtue of their extent of cross-reactivity these reagents might provide a unique resource for the detection of new viral isolates related to HIV-1.
Similar articles
-
Murine monoclonal antibodies biologically active against the amino region of HIV-1 gp120: isolation and characterization.DNA Cell Biol. 2000 Apr;19(4):243-52. doi: 10.1089/104454900314519. DNA Cell Biol. 2000. PMID: 10798448
-
Cryptic nature of a conserved, CD4-inducible V3 loop neutralization epitope in the native envelope glycoprotein oligomer of CCR5-restricted, but not CXCR4-using, primary human immunodeficiency virus type 1 strains.J Virol. 2005 Jun;79(11):6957-68. doi: 10.1128/JVI.79.11.6957-6968.2005. J Virol. 2005. PMID: 15890935 Free PMC article.
-
The effect of low-profile serine substitutions in the V3 loop of HIV-1 gp120 IIIB/LAI on the immunogenicity of the envelope protein.Virology. 1998 Nov 10;251(1):59-70. doi: 10.1006/viro.1998.9392. Virology. 1998. PMID: 9813203
-
Monoclonal antibodies to HTLV-III451 gp41: delineation of an immunoreactive conserved epitope in the transmembrane region of divergent isolates of HIV-1.AIDS Res Hum Retroviruses. 1989 Oct;5(5):479-86. doi: 10.1089/aid.1989.5.479. AIDS Res Hum Retroviruses. 1989. PMID: 2480151
-
Epitopes of HIV-1 glycoproteins recognized by the human immune system.Chem Immunol. 1993;56:91-111. Chem Immunol. 1993. PMID: 7680869 Review. No abstract available.
Cited by
-
Hyperglycosylated mutants of human immunodeficiency virus (HIV) type 1 monomeric gp120 as novel antigens for HIV vaccine design.J Virol. 2003 May;77(10):5889-901. doi: 10.1128/jvi.77.10.5889-5901.2003. J Virol. 2003. PMID: 12719582 Free PMC article.
-
Antibodies to discontinuous or conformationally sensitive epitopes on the gp120 glycoprotein of human immunodeficiency virus type 1 are highly prevalent in sera of infected humans.J Virol. 1993 Feb;67(2):863-75. doi: 10.1128/JVI.67.2.863-875.1993. J Virol. 1993. PMID: 7678308 Free PMC article.
-
Probing the structure of the human immunodeficiency virus surface glycoprotein gp120 with a panel of monoclonal antibodies.J Virol. 1994 Jan;68(1):469-84. doi: 10.1128/JVI.68.1.469-484.1994. J Virol. 1994. PMID: 7504741 Free PMC article.
-
Resistance to neutralization by broadly reactive antibodies to the human immunodeficiency virus type 1 gp120 glycoprotein conferred by a gp41 amino acid change.J Virol. 1994 Feb;68(2):674-80. doi: 10.1128/JVI.68.2.674-680.1994. J Virol. 1994. PMID: 7507184 Free PMC article.
-
Antibodies with specificity to native gp120 and neutralization activity against primary human immunodeficiency virus type 1 isolates elicited by immunization with oligomeric gp160.J Virol. 1997 Jun;71(6):4319-30. doi: 10.1128/JVI.71.6.4319-4330.1997. J Virol. 1997. PMID: 9151820 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources